Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Flory

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
JAMA Internal Medicine|January 24, 2017
Will Cardiovascular Outcomes Data on Newer Diabetes Drugs Bury the Older Agents?James Flory
JAMA|October 7, 2004
Interventions to improve research participants' understanding in informed consent for research: a systematic reviewJames Flory, Ezekiel Emanuel
Oncology (Williston Park, N.Y.)|June 17, 2016
Diabetes Management in Cancer PatientsJames Flory, Azeez Farooki
American Journal of Public Health|October 20, 2012
The prompted optional randomization trial: a new design for comparative effectiveness researchJames Flory, Jason Karlawish
JAMA|April 23, 2019
Metformin in 2019James Flory, Kasia Lipska
Archives of Internal Medicine|October 24, 2012
Charge variability for acute appendicitis: is the problem overstated?Irene Epelboym, James Flory
JAMA|October 2, 2019
Metformin for Type 2 Diabetes-ReplyJames Flory, Kasia Lipska
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|July 2, 2019
Feature Selection in Predictive Modeling: A Systematic Study on Drug Response Heterogeneity for Type II Diabetic PatientsJingyuan Chou, James Flory, Fei Wang
Current Diabetes Reports|November 29, 2019
Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology PatientsAmy Hiestand, James Flory, Ritika Chitkara
Clinical Trials (London, England)|December 12, 2017
Ethics and practice of Trials within Cohorts: An emerging pragmatic trial designScott Yh Kim, James Flory, Clare Relton
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
JAMA Internal Medicine|January 24, 2017
Will Cardiovascular Outcomes Data on Newer Diabetes Drugs Bury the Older Agents?James Flory
JAMA|October 7, 2004
Interventions to improve research participants' understanding in informed consent for research: a systematic reviewJames Flory, Ezekiel Emanuel
Oncology (Williston Park, N.Y.)|June 17, 2016
Diabetes Management in Cancer PatientsJames Flory, Azeez Farooki
American Journal of Public Health|October 20, 2012
The prompted optional randomization trial: a new design for comparative effectiveness researchJames Flory, Jason Karlawish
JAMA|April 23, 2019
Metformin in 2019James Flory, Kasia Lipska
Archives of Internal Medicine|October 24, 2012
Charge variability for acute appendicitis: is the problem overstated?Irene Epelboym, James Flory
JAMA|October 2, 2019
Metformin for Type 2 Diabetes-ReplyJames Flory, Kasia Lipska
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|July 2, 2019
Feature Selection in Predictive Modeling: A Systematic Study on Drug Response Heterogeneity for Type II Diabetic PatientsJingyuan Chou, James Flory, Fei Wang
Current Diabetes Reports|November 29, 2019
Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology PatientsAmy Hiestand, James Flory, Ritika Chitkara
Clinical Trials (London, England)|December 12, 2017
Ethics and practice of Trials within Cohorts: An emerging pragmatic trial designScott Yh Kim, James Flory, Clare Relton
Pageof 5